Magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) ablation of liver tumours

Cancer Imaging

Volumn 12, Issue 2, 2012, Pages 387-394

  Wijlemans, J W ^a   Bartels, L W ^b   Deckers, R ^b   Ries, M ^b   Mali, W P Th M ^c   Moonen, C T W ^a,b   Van Den Bosch, M A A J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NONE

Author keywords

Focused ultrasound; Interventional oncology; Liver tumour ablation; MR HIFU

Indexed keywords

B SCAN; BONE METASTASIS; CANCER PALLIATIVE THERAPY; CONFERENCE PAPER; ECHOGRAPHY; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; LIVER PERFUSION; LIVER TUMOR; MAGNETIC RESONANCE GUIDED HIGH INTENSITY FOCUSED ULTRASOUND ABLATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOFREQUENCY ABLATION; TEMPERATURE; THERMAL DIFFUSION; TUMOR ABLATION; ULTRASOUND THERAPY; UTERUS MYOMA; VOLUMETRY;

HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING;

EID: 84867910363     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2012.9038     Document Type: Conference Paper

References (59)

1. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012; 379: 1245-1255. doi:10.1016/S0140-6736(11)61347-0. PMid:22353262.
2. Wong SL, Mangu PB, Choti Ma, et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 2010; 28: 493-508. doi:10.1200/JCO.2009.23. 4450. PMid:19841322.
3. Bertot LC, Sato M, Tateishi R, et al. Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors; a systematic review. Eur Radiol 2011; 21: 2584-2596. doi:10.1007/s00330-011-2222- 3. PMid:21858539.
4. Lynn JG, Zwemer RL, Chick AJ. The biological application of focused ultrasonic waves. Science 1942; 96: 119-120. doi:10.1126/science.96.2483.119. PMid:17809987.
5. Hynynen K, Freund R, Chung H, et al. A clinical, noninvasive, MR imaging-monitored ultrasound surgery method. Radiographics 1996; 16: 185-195. PMid:10946699.
6. Hynynen K, Damianou C, Darkazanli A, et al. The feasibility of using MRI to monitor and guide noninvasive ultrasound surgery. Ultrasound Med Biol 1993; 19: 91-92. doi:10.1016/0301-5629(93)90022-G. PMid:8456533.
7. Voogt MJ, Trillaud H, Kim YS, et al. Volumetric feedback ablation of uterine fibroids using magnetic resonance-guided high intensity focused ultrasound therapy. Eur Radiol 2012; 22: 411-417. doi:10.1007/s00330-011-2262-8. PMid:21901565.
8. Huisman M, van den Bosch MA. MR-guided high-intensity focused ultrasound for noninvasive cancer treatment. Cancer Imaging 2011; 11: S161-166. doi:10.1102/1470-7330.2011.9041. PMid:22180520.
9. LeBlang SD, Hoctor K, Steinberg FL. Leiomyoma shrinkage after MRI-guided focused ultrasound treatment; report of 80 patients. Am J Roentgenol 2010; 194: 274-280. doi:10.2214/AJR.09.2842.
10. Solomon SB, Nicol TL, Chan DY, et al. Histologic evolution of high-intensity focused ultrasound in rabbit muscle. Invest Radiol 2003; 38: 293-301. PMid:12750619.
11. Schmitz AC, Gianfelice D, Daniel BL, et al. Image-guided focused ultrasound ablation of breast cancer; current status, challenges, and future directions. Eur Radiol 2008; 18: 1431-1441. doi:10.1007/s00330-008-0906-0. PMid:18351348.
12. Luo W, Zhou X, Gong X, et al. Study of sequential histopathologic changes, apoptosis, and cell proliferation in rabbit livers after high-intensity focused ultrasound ablation. J Ultrasound Med 2007; 26: 477-485. PMid:17384045.
13. Rieke V, Butts Pauly K. MR thermometry. J Magn Resonance Imaging 2008; 27: 376-390. doi:10.1002/jmri.21265. (Pubitemid 351214044)
14. McDannold NJ, King RL, Jolesz FA. Usefulness of MR imaging-derived thermometry and dosimetry in determining the threshold for tissue damage induced by thermal surgery in rabbits. Radiology 2000; 216: 517-523. PMid:10924580.
15. Ishihara Y, Calderon A, Watanabe H, et al. A precise and fast temperature mapping using water proton chemical shift. Magn Resonance Med 1995; 34: 814-823. doi:10.1002/mrm.1910340606.
16. Sapareto S, Dewey W. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984; 10: 787-800. doi:10.1016/0360-3016(84)90379-1. PMid:6547421.
17. Damianou C, Hynynen K. The effect of various physical parameters on the size and shape of necrosed tissue volume during ultrasound surgery. J Acoust Soc Am 1994; 95: 1641-1649. doi:10.1121/1.408550. PMid:8176064.
18. Dewhirst MW, Viglianti BL, Lora-Michiels M, et al. Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia 2003; 19: 267-294. doi:10.1080/0265673031000119006. PMid:12745972.
19. Yarmolenko PS, Moon EJ, Landon C, et al. Thresholds for thermal damage to normal tissues; an update. Int J Hyperthermia 2011; 27: 320-343. doi:10.3109/02656736.2010.534527. PMid:21591897.
20. Köhler MO, Mougenot C, Quesson B, et al. Volumetric HIFU ablation under 3D guidance of rapid MRI thermometry. Med Phys 2009; 36: 3521.
21. Salomir R, Palussie're J, Vimeux FC, et al. Local hyperthermia with MR-guided focused ultrasound; spiral trajectory of the focal point optimized for temperature uniformity in the target region. J Magn Reson Imaging 2000; 12: 571-583. doi:10.1002/1522-2586(200010)12:4〈571::AID-JMRI9〉3.0.CO;2-2. PMid:11042639.
22. Palussière J, Salomir R, Le Bail B, et al. Feasibility of MR-guided focused ultrasound with real-time temperature mapping and continuous sonication for ablation of VX2 carcinoma in rabbit thigh. Magn Reson Med 2003; 49: 89-98. (Pubitemid 36042337)
23. Mougenot C, Quesson B, de Senneville BD, et al. Three-dimensional spatial and temporal temperature control with MR thermometry-guided focused ultrasound (MRgHIFU). Magn Reson Med 2009; 61: 603-614. doi:10.1002/mrm.21887. PMid:19097249.
24. Ter Haar G, Sinnett D, Rivens I. High intensity focused ultrasound - a surgical technique for the treatment of discrete liver tumours. Physics Med Biol 1989; 34: 1743-1750. doi:10.1088/0031-9155/34/11/021. (Pubitemid 19265780)
25. Linke C, Carstensen E, Frizzell L, et al. Localized tissue destruction by high-intensity focused ultrasound. Arch Surg 1973; 107: 887-891. doi:10.1001/archsurg.1973.01350240053015. PMid:4751833.
26. Yang R, Reilly C, Rescorla F. High-intensity focused ultrasound in the treatment of experimental liver cancer. Arch Surg 1991; 126: 1002-1009. doi:10.1001/archsurg.1991.01410320088012. PMid:1863205.
27. Rowland IJ, Rivens I, Chen L, et al. MRI study of hepatic tumours following high intensity focused ultrasound surgery. Br J Radiol 1997; 70: 144-153. PMid:9135440.
28. Sibille A, Prat F, Chapelon JY, et al. Characterization of extracorporeal ablation of normal and tumor-bearing liver tissue by high intensity focused ultrasound. Ultrasound Med Biol 1993; 19: 803-813. doi:10.1016/0301-5629(93) 90096-7. PMid:8134980.
29. Prat F, Centarti M, Sibille A, et al. Extracorporeal high-intensity focused ultrasound for VX2 liver tumors in the rabbit. Hepatology 1995; 21: 832-836. PMid:7875681.
30. Cline E, Schenck JF, Ettinger RH, et al. Focused US system for MR imaging-guided tumor ablation. Radiology 1995; 194: 731-737. PMid:7862971.
31. Kopelman D, Inbar Y, Hanannel A, et al. Magnetic resonance-guided focused ultrasound surgery (MRgFUS). Four ablation treatments of a single canine hepatocellular adenoma. HPB (Oxford) 2006; 8: 292-298. doi:10.1080/ 13651820500465212. (Pubitemid 44044245)
32. Kopelman D, Inbar Y, Hanannel A, et al. Magnetic resonance-guided focused ultrasound surgery (MRgFUS); ablation of liver tissue in a porcine model. Eur J Radiol 2006; 59: 157-162. doi:10.1016/j.ejrad.2006.04.008. PMid:16725294.
33. Visioli aG, Rivens IH, ter Haar GR, et al. Preliminary results of a phase I dose escalation clinical trial using focused ultrasound in the treatment of localised tumours. Eur J Ultrasound 1999; 9: 11-18. doi:10.1016/S0929-8266(99) 00009-9. PMid:10099162.
34. Illing RO, Kennedy JE, Wu F, et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer 2005; 93: 890-895. doi:10.1038/sj.bjc.6602803. PMid:16189519.
35. Kennedy JE, Wu F, ter Haar GR, et al. High-intensity focused ultrasound for the treatment of liver tumours. Ultrasonics 2004; 42: 931-935. doi:10.1016/j.ultras.2004.01.089. PMid:15047409.
36. Wu F, Wang ZB, Chen WZ, et al. Extracorporeal focused ultrasound surgery for treatment of human solid carcinomas; early Chinese clinical experience. Ultrasound Med Biol 2004; 30: 245-260. doi:10.1016/j.ultrasmedbio.2003.10.010. PMid:14998677.
37. Wu F, Wang ZB, Chen WZ, et al. Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China; an overview. Ultrasonics Sonochem 2004; 11: 149-154. doi:10.1016/j. ultsonch.2004.01.011. (Pubitemid 38479821)
38. Okada A, Murakami T, Mikami K, et al. A case of hepatocellular carcinoma treated by MR-guided focused ultrasound ablation with respiratory gating. Magn Reson Med Sci 2006; 5: 167-171. doi:10.2463/mrms.5.167. PMid:17139143.
39. Ries M, de Senneville BD, Roujol S, et al. Real-time 3D target tracking in MRI guided focused ultrasound ablations in moving tissues. Magn Reson Med 2010; 64: 1704-1712. doi:10.1002/mrm.22548. PMid:20878763.
40. Cornelis F, Grenier N, Moonen CT, et al. In vivo characterization of tissue thermal properties of the kidney during local hyperthermia induced by MR-guided high-intensity focused ultrasound. NMR Biomed 2011; 24: 799-806. doi:10.1002/nbm.1624. PMid:21834004.
41. De Senneville BD, Mougenot C, Moonen CT. Real-time adaptive methods for treatment of mobile organs by MRI-controlled high-intensity focused ultrasound. Magn Reson Med 2007; 57: 319-330. doi:10.1002/mrm.21124. PMid:17260361.
42. Pernot M, Aubry J, Tanter M. High power transcranial beam steering for ultrasonic brain therapy. Physics Med Biol 2003; 48: 2577-2589. doi:10.1088/0031-9155/48/16/301. (Pubitemid 37069368)
43. Marquet F, Aubry JF, Pernot M, et al. Optimal transcostal high-intensity focused ultrasound with combined real-time 3D movement tracking and correction. Physics Med Biol 2011; 56: 7061-7080. doi:10.1088/0031-9155/56/22/005.
44. Quesson B, Merle M, Köhler MO, et al. A method for MRI guidance of intercostal high intensity focused ultrasound ablation in the liver. Med Phys 2010; 37: 2533. doi:10.1118/1.3413996. PMid:20632565.
45. Botros Y, Ebbini E, Volakis J. Optimal synthesis of phased array field patterns in the presence of the ribcage. IEEE Ultrasonics Symp 1997; 2: 1751-1754.
46. Koda M, Maeda Y, Matsunaga Y. Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm. Am J Roentgenol 2004; 183: 583-588. (Pubitemid 39145300)
47. Minami Y, Kudo M, Kawasaki T, et al. Percutaneous radiofrequency ablation guided by contrast-enhanced harmonic sonography with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. Am J Radiol 2004; 182: 1224-1226. (Pubitemid 38525518)
48. Chen L, Ter Haar G, Hill CR, et al. Effect of blood perfusion on the ablation of liver parenchyma with high-intensity focused ultrasound. Phys Med Biol 1993; 38: 1661-1673. doi:10.1088/0031-9155/38/11/011. PMid:8272440.
49. Berber E, Siperstein A. Local recurrence after laparoscopic radiofrequency ablation of liver tumors; an analysis of 1032 tumors. Ann Surg Oncol 2008; 15: 2757-2764. doi:10.1245/s10434-008-0043-7. PMid:18618182.
50. Zhang CX, Zhang Z, Chen YZ. Effects of large blood vessel locations during high intensity focused ultrasound therapy for hepatic tumors; a finite element study (conference proceedings). IEEE Engin Med Biol Soc 2005; 1: 209-212. (Pubitemid 46228831)
51. Zhang L, Zhu H, Jin C, et al. High-intensity focused ultrasound (HIFU); effective and safe therapy for hepatocellular carcinoma adjacent to major hepatic veins. Eur Radiol 2009; 19: 437-445. doi:10.1007/s00330-008-1137-0. PMid:18795303.
52. Orsi F, Zhang L, Arnone P, et al. High-intensity focused ultrasound ablation; effective and safe therapy for solid tumors in difficult locations. Am J Roentgenol 2010; 195: W245-252. doi:10.2214/AJR.09.3321.
53. Quesson B, Laurent C, Maclair G, et al. Real-time volumetric MRI thermometry of focused ultrasound ablation in vivo; a feasibility study in pig liver and kidney. NMR Biomed 2011; 24: 145-153. doi:10.1002/nbm.1563. PMid:21344531.
54. Li YY, Sha WH, Zhou YJ, et al. Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma. J Gastroenterol Hepatol 2007; 22: 2148-2154. doi:10.1111/j.1440-1746.2006.04719.x. PMid:18031373.
55. Jung SE, Cho SH, Jang JH, et al. High-intensity focused ultrasound ablation in hepatic and pancreatic cancer; complications. Abdom Imaging 2011; 36: 185-195. doi:10.1007/s00261-010-9628-2. PMid:20512487.
56. Xu G, Luo G, He L, et al. Follow-up of high-intensity focused ultrasound treatment for patients with hepatocellular carcinoma. Ultrasound Med Biol 2011; 37: 1993-1999. doi:10.1016/j.ultrasmedbio.2011.08.011. PMid:22036638.
57. Zhang Y, Zhao J, Guo D, et al. Evaluation of short-term response of high intensity focused ultrasound ablation for primary hepatic carcinoma; utility of contrast-enhanced MRI and diffusion-weighted imaging. Eur J Radiol 2011; 79: 347-352. doi:10.1016/j.ejrad.2010.06.039. PMid:20638211.
58. Jin C, Zhu H, Wang Z, et al. High-intensity focused ultrasound combined with transarterial chemoembolization for unresectable hepatocellular carcinoma; long-term follow-up and clinical analysis. Eur J Radiol 2011; 80: 662-669. doi:10.1016/j.ejrad.2010.08.042. PMid:20864286.
59. Fukuda H, Ito R, Ohto M, et al. Treatment of small hepatocellular carcinomas with US-guided high-intensity focused ultrasound. Ultrasound Med Biol 2011; 37: 1222-1229. doi:10.1016/j.ultrasmedbio.2011.04.020. PMid:21645963.